|
⚲
|
| Keyboard |
| Dolski Robert
✚
|
|
|---|---|
| CIK # | 0001840408 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001840408] | |
| 4 | [0001840408] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Dolski Robert | |
| Autolus Therapeutics PLC | |
| Checkmate Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Checkmate Pharmaceuticals Inc CMPI
Stock Option (Right to Buy) · derivative
|
2022-05-31 | Disposed to issuer | 150,000 | ||
|
Checkmate Pharmaceuticals Inc CMPI
Stock Option (Right to Buy) · derivative
|
2022-05-31 | Disposed to issuer | 27,300 | ||
|
Checkmate Pharmaceuticals Inc CMPI
Stock Option (Right to Buy) · derivative
|
2022-05-31 | Disposed to issuer | 101,180 | ||
|
Checkmate Pharmaceuticals Inc CMPI
Stock Option (Right to Buy) · derivative
|
2022-01-27 | Grant | 101,180 | $0.00 | |
|
Checkmate Pharmaceuticals Inc CMPI
Stock Option (Right to Buy) · derivative
|
2021-08-04 | Grant | 27,300 | $0.00 |